Holen Sie sich die Stockscreener-App
2.2838
3.23%
-0.0762
Schlusskurs vom Vortag:
$2.36
Offen:
$2.32
24-Stunden-Volumen:
25,562
Relative Volume:
0.13
Marktkapitalisierung:
$20.56M
Einnahmen:
$93.76M
Nettoeinkommen (Verlust:
$-13.68M
KGV:
-0.8684
EPS:
-2.63
Netto-Cashflow:
$8.77M
1W Leistung:
-1.56%
1M Leistung:
-8.28%
6M Leistung:
+117.50%
1J Leistung:
+3.34%
1-Tages-Spanne:
$2.25
$2.35
1-Wochen-Bereich:
$2.2302
$2.42
52-Wochen-Spanne:
$0.95
$2.82
Aytu Biopharma Inc Stock (AYTU) Company Profile
Firmenname
Aytu Biopharma Inc
Sektor
Telefon
(720) 437-6580
Adresse
7900 E. UNION AVENUE, DENVER
Vergleichen Sie AYTU mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AYTU
Aytu Biopharma Inc
|
2.2907 | 23.39M | 93.76M | -13.68M | 8.77M | -2.63 |
|
ZTS
Zoetis Inc
|
147.70 | 64.74B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.12 | 44.56B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.47 | 41.55B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
19.00 | 21.78B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
422.29 | 19.11B | 3.08B | 1.24B | 1.07B | 25.61 |
Aytu Biopharma Inc Stock (AYTU) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-01 | Eingeleitet | Lake Street | Buy |
| 2025-06-30 | Eingeleitet | Ascendiant Capital Markets | Buy |
| 2021-03-30 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2020-05-29 | Eingeleitet | H.C. Wainwright | Buy |
Aytu Biopharma Inc Aktie (AYTU) Neueste Nachrichten
Will Aytu BioPharma Inc. (AY20) stock announce a stock splitVolume Spike & Safe Capital Growth Tips - newser.com
Can Aytu BioPharma Inc. (AY20) stock deliver consistent EPS growthJuly 2025 Spike Watch & Weekly Market Pulse Alerts - newser.com
Will Aytu BioPharma Inc. (AY20) stock keep high P E multiplesJuly 2025 Movers & Reliable Volume Spike Alerts - newser.com
How to escape a deep drawdown in Aytu BioPharma Inc.Weekly Gains Report & Low Risk Entry Point Tips - newser.com
How institutional ownership impacts Aytu BioPharma Inc. stockJuly 2025 Market Mood & Safe Entry Trade Reports - newser.com
Tick level data insight on Aytu BioPharma Inc. volatilityQuarterly Earnings Report & Consistent Profit Trading Strategies - newser.com
What earnings revisions data tells us about Aytu BioPharma Inc.Earnings Overview Summary & AI Enhanced Trade Execution Alerts - newser.com
How to interpret RSI for Aytu BioPharma Inc. stock2025 Earnings Impact & Verified Swing Trading Watchlists - newser.com
Applying Elliott Wave Theory to Aytu BioPharma Inc.Dip Buying & Smart Allocation Stock Reports - newser.com
Will Aytu BioPharma Inc. stock attract more institutional investorsJuly 2025 Technicals & Smart Allocation Stock Tips - newser.com
Will Aytu BioPharma Inc. stock see insider buying2025 Geopolitical Influence & Advanced Swing Trade Entry Plans - newser.com
Why retail investors favor Aytu BioPharma Inc. stockMarket Weekly Review & Daily Entry Point Trade Alerts - nchmf.gov.vn
How supply chain issues affect Aytu BioPharma Inc. stockJuly 2025 News Drivers & AI Powered Trade Plan Recommendations - nchmf.gov.vn
Aytu BioPharma Inc. (NASDAQ:AYTU) Receives $9.17 Consensus PT from Brokerages - Defense World
Aytu BioPharma Inc AY20 Stock Analysis and ForecastStock Price Forecasts & Access High Yield Alerts - earlytimes.in
Is Aytu BioPharma Inc. (AY20) stock attractive for growth fundsTrade Analysis Summary & Free Technical Pattern Based Buy Signals - newser.com
Best data tools to analyze Aytu BioPharma Inc. stockJuly 2025 Summary & Trade Opportunity Analysis Reports - newser.com
Smart tools for monitoring Aytu BioPharma Inc.’s price actionJuly 2025 Breakouts & High Yield Equity Trading Tips - newser.com
Aytu BioPharma (NASDAQ:AYTU) Given Sell (D-) Rating at Weiss Ratings - Defense World
Aytu BioPharma : Corporate Presentation October 2025 View Presentation - MarketScreener
New Strong Sell Stocks for Oct. 13th - TradingView
Using data models to predict Aytu BioPharma Inc. stock movementMarket Weekly Review & Low Volatility Stock Suggestions - newser.com
Aytu BioPharma to Present at Upcoming October 2025 Conferences - ACCESS Newswire
Oct 22-23: Aytu BioPharma to Present at Maxim Growth Summit and Planet MicroCap Showcase - Stock Titan
How to use Fibonacci retracement on Aytu BioPharma Inc.Analyst Upgrade & Community Supported Trade Ideas - newser.com
Finanzdaten der Aytu Biopharma Inc-Aktie (AYTU)
Umsatz
Nettogewinn
Free Cashflow
ENV
4.98%
0.28%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):